Quantcast

Latest Stimulants Stories

2014-10-09 04:20:56

PHILADELPHIA, October 9, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it has received further guidance from the U.S. Food and Drug Administration (FDA) on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults. On April 25, 2014, in written correspondence, the FDA responded to...

2014-10-06 12:29:08

TORONTO, Oct. 6, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), today announced that Phase II data generated by the Company's principal operating subsidiary, Ironshore Pharmaceuticals & Development, Inc. ("Ironshore"), will be presented at the American Academy of Child & Adolescent Psychiatry (AACAP) Annual Meeting, which is being held October 20(th) to 25(th) in San Diego, CA. Data from the HLD-200 (methylphenidate) Phase II study, The Single Dose...

2014-10-06 08:28:52

18-MC Well Tolerated by Subjects in Development Partner's Study SAN CARLOS, Calif., Oct. 6, 2014 /PRNewswire/ -- Savant HWP, Inc., a privately held drug development company, confirmed the initiation of human safety testing of 18-MC, an experimental treatment for many forms of addiction. A single dose of 18-MC, administered as part of a double-blind, placebo-controlled human safety study conducted by Savant's South American partner, was well tolerated by healthy volunteers receiving...

2014-09-23 08:30:46

18-MC Well Tolerated by Subjects in Development Partner's Study SAN CARLOS, Calif., Sept. 23, 2014 /PRNewswire/ -- Savant HWP, Inc., a privately held drug development company, today confirmed the initiation of human safety testing of 18-MC, an experimental treatment for many forms of addiction. A single dose of 18-MC, administered as part of a double-blind, placebo-controlled human safety study conducted by Savant's South American partner, was well tolerated by healthy volunteers...

2014-09-10 08:30:23

WOODCLIFF LAKE, N.J. and SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that data from the Phase 3 clinical trial program for BELVIQ(® )(lorcaserin HCl) CIV will be presented at the American Society of Bariatric Physicians' (ASBP) 64(th) Annual Obesity & Associated Conditions Symposium taking place September 10-13, 2014, in Austin, Texas. "These data presentations continue to support Eisai's efforts to foster a greater...

electronic cigarettes and substance abuse
2014-09-04 04:00:17

Karin Eskenazi, Columbia University Medical Center Nicotine, no matter the source, may function as a gateway to marijuana and cocaine Like conventional cigarettes, electronic cigarettes (or e-cigarettes) may function as a “gateway drug” — a drug that lowers the threshold for addiction to other substances, such as marijuana and cocaine — according to the 120th Shattuck lecture, presented to the Massachusetts Medical Society by Columbia researchers Denise and Eric Kandel and...

2014-09-03 16:30:07

BALTIMORE, Sept. 3, 2014 /PRNewswire-USNewswire/ -- A study released today by the New England Journal of Medicine is claimed by the authors and the journal to suggest that e-cigarette use could cause cocaine use. In reality, the study shows no such thing, and the authors and journal are just trying to score political points based on an unimportant technical study of mice with no real-world implications. The study results only suggest that mice dosed with nicotine one day react...

shift work sleep and alertness aids
2014-08-14 03:30:14

The Cochrane Library Shift workers are taking drugs to help them stay awake or get to sleep despite weak evidence for their benefit, according to a new Cochrane review. The authors of the review found only small numbers of trials testing over-the-counter and prescription drugs used by shift workers, and the results suggest that for some people they might do more harm than good. In most developed countries, at least 10% of the workforce is involved in some form of shift work. European...

2014-08-08 11:24:34

Wolters Kluwer Health 'Substantial gaps' in knowledge of potential risks and benefits, says review in Journal of Addiction Medicine Electronic cigarettes (ECIGs) are booming in popularity—but there's still only limited evidence on their potential health risks, or their advertised benefits in helping people to quit smoking, according to a research review in the July/August Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is...

2014-07-17 16:25:39

LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies of Vyvanse(R) (lisdexamfetamine dimesylate) compared with Concerta (methylphenidate HCl) with a placebo reference arm in adolescents aged 13-17 diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). In SPD489-406, the forced-dose titration study, Vyvanse was found to be statistically superior to...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.